Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Boucher

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2009
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditisZ A Kanafani, W M Kourany, V G Fowler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?George H Talbot, Amanda Jezek, Barbara E Murray, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Anti-chemokine therapy for inflammatory diseasesM L Castellani, K Bhattacharya, M Tagen, et al.
Quality Management in Health Care|April 29, 2021
Deploying the Physician Workforce During a Respiratory Pandemic: The Experience of an Academic Teaching Hospital During the COVID-19 PandemicKari E Roberts, Sucharita Kher, Erik Garpestad, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial InfectionsKeith S Kaye, Helen W Boucher, Michelle L Brown, et al.
International Journal of Immunopathology and Pharmacology|November 13, 2003
Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actionsD Kempuraj, S Frydas, P Conti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
The Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group InnovationsScott R Evans, Robin Patel, Toshimitsu Hamasaki, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Interleukin 27 (IL-27): A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulationC Petrarca, S Frydas, J Donelan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Cell Reports. Medicine|November 1, 2021
Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learningShira Doron, Robin R Ingalls, Anne Beauchamp, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 5, 2009
Clinical characteristics and outcomes of diabetic patients with Staphylococcus aureus bacteremia and endocarditisZ A Kanafani, W M Kourany, V G Fowler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2019
The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?George H Talbot, Amanda Jezek, Barbara E Murray, et al.
International Journal of Immunopathology and Pharmacology|September 21, 2007
Anti-chemokine therapy for inflammatory diseasesM L Castellani, K Bhattacharya, M Tagen, et al.
Quality Management in Health Care|April 29, 2021
Deploying the Physician Workforce During a Respiratory Pandemic: The Experience of an Academic Teaching Hospital During the COVID-19 PandemicKari E Roberts, Sucharita Kher, Erik Garpestad, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial InfectionsKeith S Kaye, Helen W Boucher, Michelle L Brown, et al.
International Journal of Immunopathology and Pharmacology|November 13, 2003
Interleukin-25 (or IL-17E): a new IL-17 family member with growth factor/inflammatory actionsD Kempuraj, S Frydas, P Conti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2023
The Future Ain't What It Used to Be…Out With the Old…In With the Better: Antibacterial Resistance Leadership Group InnovationsScott R Evans, Robin Patel, Toshimitsu Hamasaki, et al.
International Journal of Immunopathology and Pharmacology|May 13, 2005
Interleukin 27 (IL-27): A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulationC Petrarca, S Frydas, J Donelan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Cell Reports. Medicine|November 1, 2021
Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learningShira Doron, Robin R Ingalls, Anne Beauchamp, et al.
Pageof 18